Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users

Addiction

Volumn 104, Issue 5, 2009, Pages 775-783

  Banta Green, Caleb J ^a   Maynard, Charles ^b   Koepsell, Thomas D ^c   Wells, Elizabeth A ^a   Donovan, Dennis M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Puget Sound Health Care System   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Heroin; Methadone maintenance treatment; Prescription type opioid; Public assistance; Substance abuse; Treatment retention

Indexed keywords

DIAMORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; FAMILY; FEMALE; HEALTH CARE FACILITY; HEROIN DEPENDENCE; HOUSING; HUMAN; LEGAL ASPECT; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PRESCRIPTION; PSYCHOLOGIC ASSESSMENT; RETROSPECTIVE STUDY; SELF REPORT; SOCIAL ASPECT; SOCIAL CARE; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; DRUG USERS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; WASHINGTON; YOUNG ADULT;

EID: 64149131460     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02538.x     Document Type: Article

References (31)

1. Office of Applied Studies. Treatment Episode Data Set TEDS. Rockville, MD : Substance Abuse and Mental Health Services Administration 2008. Available at: http://www.dasis.samhsa.gov/webt/tedsweb/tab-year.choose-year-web-table?t- state=US (accessed 10 February 2009).
2. Division of Alcohol and Substance Abuse. Treatment Assessment and Reports Generation Tool TARGET. Olympia, WA : Washington State Department of Social and Health Services 2008. Accessed via secure web-based interface, Treatment Analyzer, on 17 March 2008.
3. Office of Applied Studies. Overview of Findings from the 2004 National Survey on Drug Use and Health Office of Applied Studies. NSDUH Series H-27, DHHS Publication no. SMA 05-4061. Rockville, MD : Substance Abuse and Mental Health Services Administration 2005.
4. Paulozzi L. J., Budnitz D. S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006 15 : 618 27.
5. Magura S., Lee S. J., Salsitz E. A., Kolodny A., Whitley S. D., Taubes T. et al. Outcomes of buprenorphine maintenance in office-based practice. J Addict Dis 2007 262 : 13 23.
6. Moore B. A., Fiellin D. A., Barry D. T., Sullivan L. E., Chawarski M. C., O'Connor P. G. et al. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Int Med 2007 224 : 527 30.
7. Torrington M., Domier C. P., Hillhouse M., Ling W. Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting. J Addict Dis 2007 263 : 93 9.
8. Rosenblum A., Parrino M., Schnoll S. H., Fong C., Maxwell C., Cleland C. M. et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007 901 : 64 71.
9. Monga N., Rehm J., Fischer B., Brissette S., Bruneau J., El-Guebaly N. et al. Using latent class analysis LCA to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend 2007 881 : 1 8.
10. Banta-Green C., Merrill J., Jackson R., Hanrahan M. The Use & Abuse of Prescription-Type Opiates in Washington State. ADAI in Brief 2007. Available at: http://depts.washington.edu/adai/pubs/arb/PrescriptionOpiates-March30-2007. pdf (accessed 30 March 2007).
11. Trafton J. A., Oliva E. M., Horst D. A., Minkel J. D., Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend 2004 731 : 23 31.
12. French M. T., Zarkan G. A., Hubbard R. L., Rachal J. V. The effects of time in drug-abuse treatment and employment on posttreatment drug-use and criminal activity. Am J Drug Alcohol Abuse 1993 19 : 19 33.
13. Zhang Z., Friedmann P. D., Gerstein D. R. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003 98 : 673 84.
14. Wickizer T., Maynard C., Atherly A., Frederick M., Koepsell T., Krupski A. et al. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health 1994 84 : 215 21.
15. Jackson T. R., Wrede A. F., Murphy L. D., Clay C., Hanrahan M., Hagan H. et al. Recent Drug Abuse trends in the Seattle-King County Area. Rockville, MD : National Institute on Drug Abuse 1999. NIH Publication no. 99-4527: 277-294.
16. McLellan A. T., Kushner H., Metzger D. S., Peters R., Smith I., Grissom G. et al. The fifth edition of the Addiction Severity Index: historical critique and normative data. J Subst Abuse Treat 1992 9 : 199 213.
17. Donovan D. M. Assessment of addictive behaviors: implications of an emerging biopsychosocial model. In : Donovan D. M., Marlatt G. A., editors. Assessment of Addictive Behavior. New York : Guilford Press 1988, p. 3 48.
18. Peles E., Schreiber S., Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006 82 : 211 17.
19. Scott-Lennox J., Rose R., Bohlig A., Lennox R. The impact of women's family status on completion of substance abuse treatment. J Behav Health Serv Res 2000 27 : 366 79.
20. McGahan P. L., Griffith J. A., Parente R., McLellan A. T. Composite Scores From the Addiction Severity Index. Philadelphia, PA : Veterans Administration 1986.
21. Calsyn D. A., Saxon A. J., Bush K. R., Howell D. N., Baer J. S., Sloan K. L. et al. The addiction severity index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity. Drug Alcohol Depend 2004 762 : 165 71.
22. Hosmer D. W., Lemeshow S. Applied Logistic Regression, 2nd edn. New York : Wiley Inter-Science 2000.
23. StataCorp LP. Intercooled Stata 9.2 for Windows 1985-2007. College Station, TX, USA.
24. Sigmon S. C. Characterizing the emerging population of prescription opioid abusers. Am J Addict 2006 153 : 208 12.
25. Deck D., Carlson M. J. Retention in publicly funded methadone maintenance treatment in two Western states. J Behav Health Serv Res 2005 32 : 43 60.
26. Hser Y., Anglin M. D., Fletcher B. Effects of program modality and client drug dependence history on drug use reduction. J Subst Abuse Treat 1998 156 : 513 23.
27. Saxon A., Wells E., Fleming C., Jackson T. R., Calsyn D. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction 1996 91 : 1197 209.
28. Knudsen H. K., Ducharme L. J., Roman P. M. Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. J Addict Dis 2007 261 : 41 50.
29. Simpson D. D., Joe G. W., Rowan-Szal G. A., Greener J. M. Drug abuse treatment process components that improve retention. J Subst Abuse Treat 1997 14 : 565 72.
30. Brady T. A., Salvucci S., Sverdlov L. S., Male A., Kyeyune H., Sikali E. et al. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addict Dis 2005 243 : 23 47.
31. Broome K. M., Flynn P. M., Simpson D. D. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res 1999 34 : 791 806.